---
$id: https://graph.org.ai/products/commodity/51142569
$type: Product
source: UNSPSC
code: "51142569"
title: "Rasagiline methanesulfonate"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rasagiline methanesulfonate

**UNSPSC Code**: 51142569
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoamine oxidase inhibitor and antiparkinsonian agent with the molecular formula C12H13N.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LH8C2JI290, chemically known as (r)-n-2-propynyl-1-indanamine methanesulfonate, but more generally known as rasagiline methanesulfonate, which bears US NIH Compound Identifier 3052775. European Medicines Agency schedules rasagiline methanesulfonate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10261MIG. Most nations, for tariff purposes, schedule rasagiline methanesulfonate under HS 29214980. SMILES: CS(=O)(=O)O.C#CCN[C@@H]1CCC2C1CCCC2.

